Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
In 2018, the global Non-invasive Parenteral Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
GE Healthcare
Philips
Illumina
Thermo Fisher Scientific
Roche
PacBio
Perkinelmer
Qiagen
Agilent Technologies
BGI Group

Market segment by Type, the product can be split into
Instruments
Consumables

Market segment by Application, split into
Diagnostic Laboratories
Hospitals

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players.
To present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-invasive Parenteral Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.